ES8401095A1 - Procedimiento para la preparacion de 11 -cloro-15-esteroides. - Google Patents

Procedimiento para la preparacion de 11 -cloro-15-esteroides.

Info

Publication number
ES8401095A1
ES8401095A1 ES520206A ES520206A ES8401095A1 ES 8401095 A1 ES8401095 A1 ES 8401095A1 ES 520206 A ES520206 A ES 520206A ES 520206 A ES520206 A ES 520206A ES 8401095 A1 ES8401095 A1 ES 8401095A1
Authority
ES
Spain
Prior art keywords
steroids
oxo
preparation
group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520206A
Other languages
English (en)
Spanish (es)
Other versions
ES520206A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES520206A0 publication Critical patent/ES520206A0/es
Publication of ES8401095A1 publication Critical patent/ES8401095A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/12Acting on D ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES520206A 1982-04-16 1983-03-01 Procedimiento para la preparacion de 11 -cloro-15-esteroides. Expired ES8401095A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823214690 DE3214690A1 (de) 1982-04-16 1982-04-16 11ss-chlor-(delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)5(pfeil hoch)-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
ES520206A0 ES520206A0 (es) 1983-12-01
ES8401095A1 true ES8401095A1 (es) 1983-12-01

Family

ID=6161448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520206A Expired ES8401095A1 (es) 1982-04-16 1983-03-01 Procedimiento para la preparacion de 11 -cloro-15-esteroides.

Country Status (14)

Country Link
US (1) US4464365A (en, 2012)
EP (1) EP0092174B1 (en, 2012)
JP (1) JPS58188898A (en, 2012)
AT (1) ATE18408T1 (en, 2012)
AU (1) AU555285B2 (en, 2012)
CA (1) CA1244004A (en, 2012)
DD (1) DD209636A5 (en, 2012)
DE (2) DE3214690A1 (en, 2012)
DK (2) DK166089C (en, 2012)
ES (1) ES8401095A1 (en, 2012)
GR (1) GR78213B (en, 2012)
HU (1) HU186686B (en, 2012)
IE (1) IE54751B1 (en, 2012)
ZA (1) ZA832674B (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
EP2354150A1 (en) * 2010-02-09 2011-08-10 Laboratoire Theramex Process for the preparation of gestodene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3665021A (en) * 1966-07-29 1972-05-23 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-l9 nos-steroids
US3933799A (en) * 1969-01-29 1976-01-20 Glaxo Laboratories Limited 11β-Halo-9,12-unsubstituted-C19 -steroids
NL7209299A (en) * 1972-07-01 1974-01-03 Delta-4-3-oxo-11-beta-halo steroids - with hormonal activity
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU555285B2 (en) 1986-09-18
IE830765L (en) 1983-10-16
JPH0358359B2 (en, 2012) 1991-09-05
DE3362381D1 (en) 1986-04-10
EP0092174B1 (de) 1986-03-05
DK191591A (da) 1991-11-25
JPS58188898A (ja) 1983-11-04
ZA832674B (en) 1983-12-28
HU186686B (en) 1985-09-30
DK166089B (da) 1993-03-08
ATE18408T1 (de) 1986-03-15
ES520206A0 (es) 1983-12-01
DE3214690A1 (de) 1983-10-27
DK191591D0 (da) 1991-11-25
DK165879C (da) 1993-06-21
GR78213B (en, 2012) 1984-09-26
EP0092174A1 (de) 1983-10-26
AU1248883A (en) 1983-10-20
DK92183D0 (da) 1983-02-25
US4464365A (en) 1984-08-07
DK165879B (da) 1993-02-01
DD209636A5 (de) 1984-05-16
DK92183A (da) 1983-10-17
CA1244004A (en) 1988-11-01
DK166089C (da) 1993-08-02
IE54751B1 (en) 1990-01-31

Similar Documents

Publication Publication Date Title
IL58759A (en) Process for purifying proteins,pure and homogeneous interferon species obtained thereby and pharmaceutical compositions containing them
ES472838A1 (es) Procedimientos para la obtencion de derivados de 3,4,5-tri- hidropiperidina.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
ES8800272A1 (es) Un procedimiento para la preparacion de polipeptidos.
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
GR900100406A (en) Preparation process for a pharmaceutical treatment composition
ES8201549A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES8502709A1 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
ES8504447A1 (es) Un procedimiento para preparar una composicion anticaspa para el cuidado del cabello
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
DE3061127D1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
ES8401095A1 (es) Procedimiento para la preparacion de 11 -cloro-15-esteroides.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
DE3167863D1 (en) 11-methylene-delta-15 steroids, process for their preparation and pharmaceutical compositions containing them
JPS6431752A (en) Amide derivative and skin external preparation containing said derivative
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
ZA835390B (en) 7-acylthio-15,16-methylene-3-oxo-17-pregna-1,4-diene 21,17-carbolactones,their preparation and use as medicinal agents
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.
EG12274A (en) Process for the preparation of anthelmintic preparations containing 4(4-nitroanilino)-phenylisothiocyanate
DE3374401D1 (en) 4-hydroxy-alpha-ethyl benzhydroles, process for their preparation and medicines containing these compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001